Publications by authors named "Lars Wesslen"

Claim this Profile
P
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
Hege Kileng, Midori Kjellin, Dario Akaberi, Assar Bergfors, Ann-Sofi Duberg

Scand J Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.
Ida Lindström, Midori Kjellin, Navaneethan Palanisamy, Kåre Bondeson, Lars Wesslén

Infect Dis (Lond)· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.
Navaneethan Palanisamy, Axel Danielsson, Chakradhar Kokkula, Hong Yin, Kåre Bondeson

Antiviral Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bartonella spp. seroprevalence in healthy Swedish blood donors.
Svena McGill, Lars Wesslén, Eva Hjelm, Martin Holmberg, Marja Kaisa Auvinen

Scand J Infect Dis· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on trace elements, inflammation and viral clearance in the myocardium during coxsackievirus B3 infection in mice.
Eva Funseth, Lars Wesslén, Ulf Lindh, Göran Friman, Nils-Gunnar Ilbäck

Sci Total Environ· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis